Alumis (NASDAQ: ALMS) Stock Plummets After Lupus Trial Failure: A Deep Dive into the Biotechnology Company’s Future
Editor's Picks

Alumis (NASDAQ: ALMS) Stock Plummets After Lupus Trial Failure: A Deep Dive into the Biotechnology Company’s Future

September 1, 2026
Partners Group (PGPHF) H1 Profit Falls, New Co-CEOs Appointed
Editor's Picks

Partners Group (PGPHF) H1 Profit Falls, New Co-CEOs Appointed

September 1, 2026
Alarum Technologies Ltd. (NASDAQ:ALAR) Faces Legal Challenges Ahead of Q3 Earnings Report
Editor's Picks

Alarum Technologies Ltd. (NASDAQ:ALAR) Faces Legal Challenges Ahead of Q3 Earnings Report

September 1, 2026
Editor's Picks
Top Market Gainers: SPACs, Biotech, Geothermal, AI Stocks Rally

Top Market Gainers: SPACs, Biotech, Geothermal, AI Stocks Rally

September 1, 2026

Top Market Gainers: SPAC Volatility, Biotech, Geothermal Energy, and AI Stocks Rally Rising Dragon Acquisition Corp. (NASDAQ: RDAC) surged amid continued volatility in the low-float SPAC. bioAffinity Technologies Inc. (NASDAQ:...

Editor's Picks

Alumis Plunges on Trial, Enovis Falls on Acquisition; ETFs Decline

Alumis Plunges on Trial, Enovis Falls on Acquisition; ETFs Decline

September 1, 2026
Enovis (NYSE: ENOV) Stock Analysis: Price Target Adjustment Amidst Strategic Robotics Acquisition

Enovis (NYSE: ENOV) Stock Analysis: Price Target Adjustment Amidst Strategic Robotics Acquisition

September 1, 2026
Citigroup Reaffirms NIO Buy, Lowers Price Target to $7.10

Citigroup Reaffirms NIO Buy, Lowers Price Target to $7.10

September 1, 2026
Yum! Brands, Inc. (NYSE:YUM) Faces Legal Scrutiny Amid Insider Sale and Food Safety Concerns

Yum! Brands, Inc. (NYSE:YUM) Faces Legal Scrutiny Amid Insider Sale and Food Safety Concerns

September 1, 2026

Meme Stock Alert!!!
Be in the know for the next Market Trend

We will not share your information & you can unsubscribe at any time. You agree to our terms of service & privacy policy. You agree to receive emails & correspondence from Nextmemealert.